End-of-day quote
Shanghai S.E.
18:00:00 2024-05-14 EDT
|
5-day change
|
1st Jan Change
|
19.94
CNY
|
-0.35%
|
|
-3.34%
|
-26.23%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,554
|
3,419
|
2,923
|
2,148
|
-
|
-
|
Enterprise Value (EV)
1 |
4,554
|
3,419
|
2,923
|
2,148
|
2,148
|
2,148
|
P/E ratio
|
27.5
x
|
76.9
x
|
-30.4
x
|
133
x
|
16.8
x
|
24.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
2.43
x
|
2.37
x
|
1.62
x
|
1.16
x
|
1.26
x
|
EV / Revenue
|
-
|
2.43
x
|
2.37
x
|
1.62
x
|
1.16
x
|
1.26
x
|
EV / EBITDA
|
-
|
-
|
99.5
x
|
5.41
x
|
3.47
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.29
x
|
1.15
x
|
0.84
x
|
0.74
x
|
0.8
x
|
Nbr of stocks (in thousands)
|
108,406
|
108,406
|
108,144
|
107,799
|
-
|
-
|
Reference price
2 |
42.01
|
31.54
|
27.03
|
19.94
|
19.94
|
19.94
|
Announcement Date
|
2/25/22
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,410
|
1,235
|
1,326
|
1,854
|
1,704
|
EBITDA
1 |
-
|
-
|
29.37
|
397
|
620
|
-
|
EBIT
1 |
-
|
67.58
|
-90.31
|
29
|
160.5
|
114
|
Operating Margin
|
-
|
4.79%
|
-7.31%
|
2.19%
|
8.65%
|
6.69%
|
Earnings before Tax (EBT)
1 |
-
|
59.49
|
-101.3
|
20
|
151.5
|
105
|
Net income
1 |
165.7
|
44.49
|
-96.14
|
16.76
|
132.2
|
89
|
Net margin
|
-
|
3.16%
|
-7.78%
|
1.26%
|
7.13%
|
5.22%
|
EPS
2 |
1.530
|
0.4100
|
-0.8900
|
0.1500
|
1.185
|
0.8000
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/25/22
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
1.63%
|
-3.59%
|
0.64%
|
4.16%
|
3.21%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-2.38%
|
0.4%
|
2.15%
|
1.8%
|
Assets
1 |
-
|
-
|
4,046
|
4,190
|
6,148
|
4,944
|
Book Value Per Share
2 |
-
|
24.50
|
23.60
|
23.70
|
27.00
|
24.90
|
Cash Flow per Share
2 |
-
|
1.300
|
0.6400
|
1.060
|
1.290
|
2.000
|
Capex
1 |
-
|
326
|
240
|
430
|
623
|
430
|
Capex / Sales
|
-
|
23.14%
|
19.42%
|
32.43%
|
33.59%
|
25.23%
|
Announcement Date
|
2/25/22
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Last Close Price
19.94
CNY Average target price
33
CNY Spread / Average Target +65.50% Consensus |
1st Jan change
|
Capi.
|
---|
| -26.23% | 298M | | +17.18% | 66.52B | | +3.18% | 50.34B | | +18.17% | 42.01B | | +20.88% | 26.68B | | +12.33% | 19.97B | | +0.87% | 17.32B | | -23.54% | 15.7B | | +1.47% | 15.53B | | -11.52% | 14.99B |
Other Specialty Chemicals
|